×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Leadership | BioMarin
BioMarin Pharmaceutical Inc.
BioMarin Leadership Team. Under the leadership of our President and Chief Executive Officer Alexander Hardy, the BioMarin Leadership Team includes accomplished...
1 month ago
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2024 Earnings Call Transcript
MSN
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2024 Earnings Call Transcript April 24, 2024 BioMarin Pharmaceutical Inc. beats earnings expectations.
3 days ago
BioMarin sheds 170 jobs in wake of narrowed R&D refocus
Fierce Biotech
BioMarin had already announced plans to cut its pipeline in half, but now 170 employees are also leaving the building as part of the R&D...
5 days ago
BioMarin Pharmaceutical to Discontinue Certain R&D Programs, Cut About 170 Jobs
MarketWatch
By Mary de Wet BioMarin Pharmaceutical will discontinue certain research and development programs and cut about 170 jobs as part of its...
6 days ago
Biopharma Layoff Tracker 2024: Erasca, Bolt, Tenaya and More Cut Staff
BioSpace
Follow along as BioSpace keeps you up-to-date on the latest pharma and biotech layoffs.
3 days ago
BioMarin cutting about 170 jobs after shuffling drug portfolio
The Business Journals
The cuts are the latest stemming from an agreement last year with an activist shareholder aimed at maximizing BioMarin's long-term value.
6 days ago
Biotech company lays off over a hundred Bay Area workers
SFGATE
BioMarin Pharmaceutical, a San Rafael-based biotech company specializing in drugs for genetic disorders, is laying off swaths of its Bay...
4 days ago
BioMarin confirms layoffs and R&D cuts
LabPulse.com
BioMarin Pharmaceutical, maker of targeted therapies for genetic conditions, will lay off 170 workers through the end of July, in connection...
5 days ago
Novo Holdings buys stake in life sciences tools company; BioMarin lays off 170
Yahoo Finance
The parent of Novo Nordisk is acquiring 60% ownership of Single Use Support, which specializes in handling of advanced therapies.
5 days ago
BioMarin Pharmaceutical to lay off 170 employees (NASDAQ:BMRN)
Seeking Alpha
BioMarin Pharmaceutical will lay off 170 employees due to the termination of certain research programs. Read more here.
6 days ago